drugset / Trial / NCT03624023
TWB-103 for Treating Lower Limb Ulcers on Patients With DM
NaSingle-groupOpen-labelTreatment
Summary
Primary Objective: To assess the safety profile of TWB-103 administered to subjects with diabetic lower limb ulcers Secondary Objective: To explore the efficacy of TWB-103 administered to subjects with diabetic lower limb ulcers
Timeline
- Start
- 2019-12-19
- Primary completion
- 2021-07-09
- Completion
- 2021-07-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TWB-103 | Unknown | — | Topical |